11.30.17 | Policy SWHR Urges ICER to Consider Disease Burden When Assessing Migraine Drugs
SWHR provided initial input to the Institute for Clinical and Economic Review (ICER) as it prepares to assess the effectiveness […]
11.27.17 | Policy SWHR Concerns on Clinical Laboratory Fee Schedule
In letters to the U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services, SWHR expressed serious […]
11.10.17 | Policy SWHR Input on NIH Strategic Plan for Women’s Health Research
SWHR provided input on the National Institutes of Health (NIH) strategic plan for research on women’s health to stimulate new […]
5.22.17 | Policy SWHR Supports Continuation of FDA User Fee Programs
SWHR issued a letter supporting the continuation of the Food and Drug Administration (FDA) user fee programs in order to […]
7.13.16 | Policy SWHR Comments on USPSTF Draft Recommendations for Sleep Apnea Screening
SWHR’s Sleep Network provided comments to the U.S. Preventive Services Task Force (USPSTF) on its draft recommendation on screening for […]
